Literature DB >> 22502915

Diabetic retinopathy: a new predictor in patients on regular hemodialysis.

Ayman El-Menyar1, Hassan Al Thani, Ahmed Hussein, Ahmed Sadek, Ahmed Sharaf, Jassim Al Suwaidi.   

Abstract

BACKGROUND: Data evaluating the presence and impact of diabetic retinopathy (DR) in patients on regular hemodialysis (HD) are scarce.
OBJECTIVE: To assess prevalence and outcomes of DR in HD patients.
METHODS: Data were collected from 252 consecutive HD-dependent patients who underwent eye examination for detection of DR in 2007. Patients were divided into two groups (DR vs. no-DR) and followed up for 3 years. Demographic and clinical profiles were analyzed and compared. Multivariate logistic regression was used to find out the predictors of DR, morbidity and mortality.
RESULTS: DR was diagnosed in 113 patients (45%). In comparison to no-DR, DR patients were older and more likely to have high prevalence of dyslipidemia, coronary artery disease and cerebrovascular accidents. Duration of DM was longer in DR patients (p = 0.02). There was significant correlation between DR and nephropathy (r = 0.38; p = 0.001) and PAD (r = 0.27; p = 0.001). Hemoglobin A1c, serum calcium and total cholesterol were higher while serum albumin and phosphorus were lower in DR in comparison to no-DR group. The rates of renal transplant, coronary artery disease and cerebrovascular accidents were comparable in the two groups. Peripheral arterial disease (PAD) was associated with 4-fold increase in the presence of DR (Adjusted OR 3.9; p = 0.009). DR was independent predictor for PAD (adjusted OR 2.2; p = 0.01). Age-sex adjusted DR was independent predictor of 3-year mortality (OR 2.04; p = 0.03). LIMITATIONS: The main issue with a cross-sectional study such as this, is differentiating cause and effect from simple association. Also, the current study did not specify the severity of DR.
CONCLUSION: Prevalence of DR is high among HD patients and associated with high mortality. DR is an independent predictor for PAD and not for transplantation. Early detection of DR is highly recommended among HD population for risk-stratification and counseling. Further randomized controlled studies are needed to support our finding.

Entities:  

Mesh:

Year:  2012        PMID: 22502915     DOI: 10.1185/03007995.2012.684675

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  6 in total

1.  Prevention of type II diabetes mellitus in Qatar: Who is at risk?

Authors:  Paul J Christos; Hiam Chemaitelly; Laith J Abu-Raddad; Mahmoud Ali Zirie; Dirk Deleu; Alvin I Mushlin
Journal:  Qatar Med J       Date:  2014-12-09

Review 2.  Traumatic injuries in patients with diabetes mellitus.

Authors:  Ayman El-Menyar; Ahammed Mekkodathil; Hassan Al-Thani
Journal:  J Emerg Trauma Shock       Date:  2016 Apr-Jun

3.  Prevalence of undiagnosed diabetic retinopathy among inpatients with diabetes: the diabetic retinopathy inpatient study (DRIPS).

Authors:  Jessica J Kovarik; Andrew W Eller; Lauren A Willard; Jiaxi Ding; Jann M Johnston; Evan L Waxman
Journal:  BMJ Open Diabetes Res Care       Date:  2016-02-16

4.  High Incidence of Adverse Outcomes in Haemodialysis Patients with Diabetes with or without Diabetic Foot Syndrome: A 5-Year Observational Study in Lleida, Spain.

Authors:  Montserrat Dòria; Àngels Betriu; Montserrat Belart; Verónica Rosado; Marta Hernández; Felipe Sarro; Jordi Real; Esmeralda Castelblanco; Linda Roxana Pacheco; Elvira Fernández; Josep Franch-Nadal; Mònica Gratacòs; Dídac Mauricio
Journal:  J Clin Med       Date:  2021-03-26       Impact factor: 4.241

5.  Serum magnesium in diabetic retinopathy: the association needs investigation.

Authors:  Koushik Shivakumar; A R Rajalakshmi; Kirti Nath Jha; Swathi Nagarajan; A R Srinivasan; A Lokesh Maran
Journal:  Ther Adv Ophthalmol       Date:  2021-12-05

6.  Prevalence of Diabetic Foot Disease in Patients with Diabetes Mellitus under Renal Replacement Therapy in Lleida, Spain.

Authors:  Montserrat Dòria; Verónica Rosado; Linda Roxana Pacheco; Marta Hernández; Àngels Betriu; Joan Valls; Josep Franch-Nadal; Elvira Fernández; Dídac Mauricio
Journal:  Biomed Res Int       Date:  2016-04-14       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.